Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Eocene Ltd.

Eocene Ltd. (EOCN) Stock Overview

Explore Eocene Ltd.’s financial performance, market position, analyst ratings, and future outlook.

EOCN●NASDAQ
HealthcareMedical - Pharmaceuticals
$3.50
$0.13(3.86%)
U.S. Market opens in 3h 37m

Eocene Ltd. (EOCN)

Meyka AI Score

Z

Key Financials

Market Cap3.6M
P/E RatioN/A
EPS (TTM)$-13.81
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$1.21
3 Months$12.78
1 Year TargetN/A

EOCN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Eocene Ltd. (NASDAQ: EOCN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Eocene Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of EOCN on the NASDAQ shows an RSI of 21.96, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Eocene Ltd.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 3.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of EOCN on the NASDAQ.

Price Performance (NASDAQ: EOCN)

1-Day Change
1.83%
5-Day Change
-1.95%
1-Month Change
-20.38%
3-Month Change
-16.30%
6-Month Change
-16.30%
Year-to-Date (YTD) Change
-16.30%
1-Year Change
-16.30%
3-Year Change
-16.30%
5-Year Change
-16.30%
All-Time (Max) Change
-16.30%

Contact Information

http://galmedpharma.com
NaN
16 Abba Hillel Road, Ramat Gan, TA, 5250608

Company Facts

60 Employees
IPO DateSep 10, 2026
CountryIL
Actively Trading

Frequently Asked Questions